- Home
- VYGR vs PINE Comparison
VYGR vs PINE Comparison
Compare VYGR & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- PINE
- Stock Information
- Founded
- VYGR 2013
- PINE 2019
- Country
- VYGR United States
- PINE United States
- Employees
- VYGR N/A
- PINE N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- PINE Real Estate Investment Trusts
- Sector
- VYGR Health Care
- PINE Real Estate
- Exchange
- VYGR Nasdaq
- PINE Nasdaq
- Market Cap
- VYGR 206.9M
- PINE 200.1M
- IPO Year
- VYGR 2015
- PINE 2019
- Fundamental
- Price
- VYGR $3.36
- PINE $15.21
- Analyst Decision
- VYGR Strong Buy
- PINE Strong Buy
- Analyst Count
- VYGR 7
- PINE 5
- Target Price
- VYGR $14.50
- PINE $18.30
- AVG Volume (30 Days)
- VYGR 725.5K
- PINE 69.3K
- Earning Date
- VYGR 08-06-2025
- PINE 10-16-2025
- Dividend Yield
- VYGR N/A
- PINE 7.49%
- EPS Growth
- VYGR N/A
- PINE N/A
- EPS
- VYGR N/A
- PINE N/A
- Revenue
- VYGR $42,580,000.00
- PINE $56,340,000.00
- Revenue This Year
- VYGR N/A
- PINE $14.51
- Revenue Next Year
- VYGR $107.07
- PINE $0.12
- P/E Ratio
- VYGR N/A
- PINE N/A
- Revenue Growth
- VYGR N/A
- PINE 17.14
- 52 Week Low
- VYGR $2.65
- PINE $13.95
- 52 Week High
- VYGR $8.28
- PINE $19.42
- Technical
- Relative Strength Index (RSI)
- VYGR 49.16
- PINE 63.57
- Support Level
- VYGR $3.30
- PINE $15.05
- Resistance Level
- VYGR $3.49
- PINE $15.37
- Average True Range (ATR)
- VYGR 0.21
- PINE 0.24
- MACD
- VYGR -0.02
- PINE 0.09
- Stochastic Oscillator
- VYGR 33.33
- PINE 87.69
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.